Page 7 of 12 – SEC Filing 1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kovner, Bruce 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] 3. SEC USE ONLY 4. SOURCE OF FUNDS AF, PF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_] 6. CITIZENSHIP OR PLACE OF ORGANIZATION United States NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON 7. SOLE VOTING POWER 5,443,823 8. SHARED VOTING POWER 16,398,839 9. SOLE DISPOSITIVE POWER 5,443,823 10. SHARED DISPOSITIVE POWER 16,398,839 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 21,842,662 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [_] 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 15.8% 14. TYPE OF REPORTING PERSON IN
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| 1. | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | |
| Kovner, Bruce | ||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | (a) [_] |
| (b) [X] | ||
| 3. | SEC USE ONLY | |
| 4. | SOURCE OF FUNDS | |
| AF, PF | ||
| 5. | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) | [_] |
| 6. | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| United States | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||
| 7. | SOLE VOTING POWER | |
| 5,443,823 | ||
| 8. | SHARED VOTING POWER | |
| 16,398,839 | ||
| 9. | SOLE DISPOSITIVE POWER | |
| 5,443,823 | ||
| 10. | SHARED DISPOSITIVE POWER | |
| 16,398,839 | ||
| 11. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 21,842,662 | ||
| 12. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES | [_] |
| 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) | |
| 15.8% | ||
| 14. | TYPE OF REPORTING PERSON | |
| IN | ||
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Follow Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
